Our documents

Scientific watch for new therapies indicated in the treatment of rare conditions as well as cell and gene technologies

Presentation of our Scientific watch for new therapies indicated in the treatment of rare conditions as well as cell and gene technologies.   Produced by Synergyx Conseils ...

Montréal InVivo’s Activity Report 2022

Law 25 – What to expect

Law 25 will gradually come into force over the next three years, starting on September 22, 2022. In the attached document, you will find the measures required by the law and the...

The Rare Diseases Strategic Action Plan 2022

Although Quebec does not yet have a policy or action plan specific to rare diseases, the life sciences community and Quebec families affected by one of these diseases have proac...

Executive summary of the Rare Diseases strategic action plan 2022

Montréal InVivo’s Activity Report 2021

Presentation of the Rare Disease Strategic Action Plan 2022

Montreal InVivo has created a Rare Disease Project Committee, representing the entire ecosystem, to propose a national plan! The presentation highlights the need for rare diseas...

Launch of the 3nd Grant Award – Life Sciences Entrepreneurship Development Program

The partners of the Life Sciences Entrepreneurship Development Program are pleased to offer 5 scholarships which will cover the full cost of the program to entrepreneurs and SME...